[Acquired rifampicin resistance during M. kansasii infection in a patient with AIDS]. / Résistance acquise à la rifampicine au cours d'une infection à M. kansasii chez un patient atteint de SIDA.
Rev Mal Respir
; 9(4): 464-6, 1992.
Article
em Fr
| MEDLINE
| ID: mdl-1509191
ABSTRACT
A man with AIDS and M. kansasii lung infection received rifampicin and isoniazid for 9 months, combined with ethambutol for four months. The treatment was effective with sputum culture negativation, but relapse occurred. The minimal inhibitory concentration of rifampicin for the M. kansasii strain was respectively 0.2 microgram/ml at the onset and 128 micrograms/ml after the treatment, giving evidence of acquired resistance. A new treatment was initiated but is was ineffective.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Rifampina
/
Tuberculose Pulmonar
/
Síndrome da Imunodeficiência Adquirida
/
Micobactérias não Tuberculosas
/
Infecções por Mycobacterium não Tuberculosas
Limite:
Adult
/
Humans
/
Male
Idioma:
Fr
Revista:
Rev Mal Respir
Ano de publicação:
1992
Tipo de documento:
Article